- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02352194
Physical Capacity and Rehabilitation of Patients With Multiple Sclerosis (REHABSEP)
Observational Study of the Physical Capacity of Patients With Multiple Sclerosis and Evaluation of the Effects of Usual Rehabilitation in the Day Hospital
Study Overview
Detailed Description
Single center, retrospective and prospective study.
In order to assess the efficiency of the of usual rehabilitation proposed to patients in the day hospital, assessments are systematically performed before and after the rehabilitation program:
Assessment of muscular strength and fatigue:
Assessments of voluntary force will be those usually performed in the context of the evaluation of patients. The isokinetic dynamometer CON-TREX ® is a device that provides a quantified result of the torque developed in a predetermined joint area with a constant speed which is also defined in advance.
The assessment includes an assessment of the strength in isometric contraction (at 40 and 90 degrees of knee flexion) and concentric contraction (30, 60 and 90 degrees per second). Fatigue is evaluated by two self-administered questionnaires: the Fatigue Severity Scale and Modified Fatigue Impact Scale.
Effort test:
The aerobic capacity of patients will be assessed by a triangular maximal exercise test.
The effort test is performed on a cycle ergometer from a triangular incremental exercise. Beforehand, blood pressure and ECG are recorded to establish that the patient can safely achieve a gradual stress test. Heart rate, blood pressure, oxygen consumption, the feeling (Borg scale) and ECG are recorded immediately before and immediately after the end of the test and every minute for at least 5-10 minutes during the recovery phase.
- Clinical assessment:
The Timed Up and Go test will be used to assess the patient's capacity of postural transition.
This is a timed quantitative assessment of the duration needed to change from sitting in a chair, get up and walk three meters, make a U-turn and come back to sit down.
The 10 meters test quantifies the walking speed of patients (meters / second) over 10 meters A test of ascending and descending10 stairs is also performed, as well as the 6 minutes walking test.
In addition to these functional assessments, clinical tests are conventionally performed such as the measurement of muscle strength (Medical Research Council scale), range of motion, spasticity (modified Ashworth scale) and an assessment of the balance and posture.
The SEP-59 questionnaire will be used to assess the patients quality of life.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Garches, France, 92380
- Recruiting
- Raymond Poincaré Hospital
-
Contact:
- Djamel Bensmail, MD,PhD
- Phone Number: +33147107060
- Email: djamel.bensmail@rpc.aphp.fr
-
Contact:
- Hameau Sophie
- Phone Number: +33171144921
- Email: sophie.hameau@rpc.aphp.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Multiple Sclerosis with EDSS ≤ 6 (Expanded Disability Status Scale)
- Patient ≥ 18 years old
- Patient able to comply with the recommended monitoring
- No relapse within the last three months
- More than six months elapsed since last medical care in day hospital
- No recent modification (six month) of medications for MS
- More than three months elapsed since last change of associated treatments (Fampyra, botulinum toxin)
Exclusion Criteria:
- Patients under any form of guardianship or curatorship
- Breastfeeding
- Orthopedic complications with repercussions on walking activities
- No affiliation to a social security scheme (beneficiary or assignee)
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Assessment
One part of this study is to quantify physical capacity of patients with Multiple sclerosis. Thirty patients will be enrolled in this study and performed assessments. |
|
|
Rehabilitation
A second part of this study is to quantify the benefit of a usual rehabilitation program in the day hospital.
Thirty patients will be enrolled in this study and receive rehabilitation.
They will be assessed before and after the rehabilitation program (physiotherapy and physical activity)
|
Physiotherapy and physical activity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Assessment of the strength and fatigue
Time Frame: Within 10 weeks from the start of the rehabilitation program
|
Assessment realised with an isokinetic dynamometer
|
Within 10 weeks from the start of the rehabilitation program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6 minutes walking test
Time Frame: Within 10 weeks from the start of the rehabilitation program
|
Patients were instructed to walk as far as possible in a 50 meters corridor during 6 minutes
|
Within 10 weeks from the start of the rehabilitation program
|
|
Evaluation of aerobic capacity during an effort test
Time Frame: Within 10 weeks from the start of the rehabilitation program
|
Aerobic capacity (VO2max)
|
Within 10 weeks from the start of the rehabilitation program
|
|
Assessment of the balance of patients
Time Frame: Within 10 weeks from the start of the rehabilitation program
|
Berg Balance Scale
|
Within 10 weeks from the start of the rehabilitation program
|
|
Assessment of Spasticity with the Modified Ashworth Scale (MAS),
Time Frame: Within 10 weeks from the start of the rehabilitation program
|
Within 10 weeks from the start of the rehabilitation program
|
|
|
10 meters Walk test
Time Frame: Within 10 weeks from the start of the rehabilitation
|
Patients have to walk over a 14 meter walkway and time required to traverse the middle 10 meters of the walk was recorded to avoid acceleration and deceleration effects
|
Within 10 weeks from the start of the rehabilitation
|
|
Timed up and go test
Time Frame: Within 10 weeks from the start of the rehabilitation
|
Patients have to get up from a chair, walk 3 meters, turn around and return to sitting as quickly as possible
|
Within 10 weeks from the start of the rehabilitation
|
|
Time to ascend and descend stairs
Time Frame: Within 10 weeks from the start of the rehabilitation
|
Participants were instructed to ascend and descend 10 stairs using the hand rail
|
Within 10 weeks from the start of the rehabilitation
|
|
Assessment of Strength with the Medical Research Council (MRC),
Time Frame: Within 10 weeks from the start of the rehabilitation
|
Within 10 weeks from the start of the rehabilitation
|
|
|
Assessment of Quality of Life with SEP-59 Scale
Time Frame: Within 10 weeks from the start of the rehabilitation
|
Within 10 weeks from the start of the rehabilitation
|
|
|
Assessment of the balance of patients
Time Frame: Within 10 weeks from the start of the rehabilitation
|
Postural control assessment : eyes opened and eyes closed
|
Within 10 weeks from the start of the rehabilitation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Djamel Bensmail, MD,PhD, Physical and Rehabilitation Medicine department, Raymond Poincaré Hospital,
- Study Director: Raphael Zory, PhD, LAMHESS Laboratory, Faculty of Sports Science, 06205 Nice, France
- Study Director: Sophie Hameau, Physical and Rehabilitation Medicine department, Raymond Poincaré Hospital,
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-REHABSEP
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis (MS)
-
University of California, San FranciscoGenentech, Inc.RecruitingMultiple Sclerosis | MS (Multiple Sclerosis) | MS | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary ProgressiveUnited States
-
Association de Recherche Bibliographique pour les...Centre Hospitalier Universitaire de Nice; Centre Hospitalier Princesse GraceCompletedHealthy | Clinically Isolated Syndrome | Multiple Sclerosis (MS) | Radiologically Isolated Syndrome | Multiple Sclerosis (MS) Relapsing Remitting | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary ProgressiveMonaco
-
Moein AminNovartis PharmaceuticalsNot yet recruitingMultiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary ProgressiveUnited States
-
University of Illinois at ChicagoRecruitingMultiple Sclerosis | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis Acute and Progressive | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary ProgressiveUnited States
-
Shirley Ryan AbilityLabNot yet recruitingMultiple Sclerosis | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary Progressive
-
Tr1X, Inc.RecruitingMultiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis (SPMS) | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary ProgressiveUnited States
-
GeNeuro Innovation SASCompletedMultiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MSFrance, Spain, Switzerland
-
German University in CairoCompletedMultiple Sclerosis (MS) - Relapsing-remittingEgypt
-
Xijing HospitalHebei Senlang Biotechnology Co., LTDNot yet recruitingMultiple Sclerosis | Multiple Sclerosis (MS) Primary Progressive | Multiple Sclerosis (MS) Secondary Progressive | Refractory Multiple SclerosisChina
-
Uppsala UniversityActive, not recruitingMultiple Sclerosis (Relapsing Remitting) | MS (Multiple Sclerosis) | Multiple Sclerosis (MS) - Relapsing-remittingSweden
Clinical Trials on Rehabilitation
-
Tuba MadenCompletedMultiple Sclerosis | Postural Balance | Cervical Region Disorder Nos | Muscle Tonus | ProprioceptionTurkey
-
IRCCS San Camillo, Venezia, ItalyIRCCS San Raffaele; Istituto Universitario di Studi Superiori PaviaRecruitingStroke | Schizophrenia | Traumatic Brain InjuryItaly
-
I.R.C.C.S. Fondazione Santa LuciaCompleted
-
Hopital FochRecruitingSpinal Cord InjuriesFrance
-
Azienda Ospedaliera Città della Salute e della...CompletedAdolescent | Child | Hematopoietic Stem Cell TransplantationItaly
-
Istituti Clinici Scientifici Maugeri SpARecruitingCognitive Impairment | Dementia | Vascular Dementia | Dementia, Mixed | Comorbidities and Coexisting ConditionsItaly
-
Poznan University of Medical SciencesCompleted
-
Centre Hospitalier Universitaire de Saint EtienneMinistry of Health, FranceCompletedPulmonary Arterial HypertensionFrance
-
Campus Bio-Medico UniversityRecruitingLow Back Pain | Rehabilitation | Orthopedic Disorder | Physical Therapy | Core StrengtheningItaly
-
The First Affiliated Hospital with Nanjing Medical...Unknown